Mesalamine Tablet, Delayed Release
Product Images NDC 84612-175

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 84612-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nuvaila Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label-mesalamine Dr Tablets (Label Mesalamine Dr Tablets)

Mesalamine Delayed-Release Tablets, USP 1.2 g, oral tablets labeled for prescription use, supplied in a 120-tablet package. Manufactured by Sun Pharmaceutical Industries Limited and labeled for Nuvaila Limited, the label includes dosage information, storage instructions, and a barcode.*

FDA Label Image

Mesalamine Structural Formula (Mesalamine Structural Formula)

Chemical structure of Mesalamine showing a benzene ring with amino, hydroxyl, and carboxyl functional groups. The image includes the molecular formula C7H7NO3 and molecular weight 153.14.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.